Merrill Lynch Biotech Sector Outlook and Making Your Capital Work for You – Hosted by EWIB CT

Join Executive Women In Bio-Connecticut, Merrill Lynch’s Amanda Castellano, and analyst Geoff Meacham for a Fireside chat. They will be discussing the 2023 biotech sector outlook and strategies for generating yields to get the most out of your capital.

Speakers:

Amanda Castellano, Financial Advisor, Senior Portfolio Advisor at Merrill Lynch

Amanda Castellano’s commitment to women in business has been longstanding. As a young entrepreneur, Amanda started her own wellness and fitness company specializing in empowering female clients with the tools necessary to lead a life of health and confidence. While pursuing a Bachelor of Science degree at St. Francis College, Amanda volunteered at the local bereavement center and offered support to women in their time of need. As a Financial Advisor at Merrill Lynch, Amanda is fortunate enough to be able to work with biotech executives and founders, female entrepreneurs, and professional athletes. Having an understanding of the entrepreneurial spirit that drives her clients through her own experience, Amanda is committed to empowering them with the expert guidance and resources they need to succeed financially in their personal and professional pursuits.

Outside of work, Amanda enjoys spending time with family and friends and furthering her passion for volunteerism. Amanda serves on the Board of the Westport Young Woman’s League and is the current Chair of the Minute Man Race, a popular annual event that raises thousands of dollars for various charities throughout Fairfield County. She is also a board member of the Women’s Business Development Council and is a regular supporter of the Bridgeport Rescue Mission and Gillespie Center for those in need. Amanda’s other passions include education and the arts. She serves on the committee that oversees the Westport Public Arts Collection and is also a supporter of the Westport Country Playhouse. Amanda enjoys volunteering at the local schools as well, volunteering with the ArtSmart program and sustainability initiatives.

Geoff Meacham, Managing Director at Bank of America Merrill Lynch

Geoff Meacham is a Managing Director in Americas Equity Research, covering the Biotechnology and Major Pharmaceuticals sectors in the US. He has been with the firm since the fall of 2019. Meacham has been highly ranked in the Institutional Investor All-America Research Poll for over ten years in the Large Cap Biotechnology Category and, more recently, the Major Pharma Category. Previously, he was a Managing Director at Barclays, covering the US Biotech and Pharma sectors for five years, and, prior to that, he was Managing Director at JPMorgan, covering the US Biotech sector (large and SMid cap) for ten years. Meacham began his career as an equity research analyst in 2000 at UBS, covering a number of sectors in Healthcare, including SMid Biotech, Life Science Tools, and SMid Med Tech. He has a PhD in molecular cell Biology from the University of Alabama-Birmingham (UAB) and a BS in biology/microbiology from the University of Georgia.